SignalXSignalX

LGND LIGAND PHARMACEUTICALS INC

8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical Preparations
LIGAND PHARMACEUTICALS INC Overview

LIGAND PHARMACEUTICALS INC (LGND) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 earnings announced Feb 26, 2026; results in Exhibit 99.1
  • • Filing covers periods ending Dec 31, 2025 — key figures in the press release, not in this item
+1 more insights

Get deeper insights on LIGAND PHARMACEUTICALS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.